Page last updated: 2024-08-21

isoxazoles and Diabetic Nephropathies

isoxazoles has been researched along with Diabetic Nephropathies in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Cheon, J; Jun, HS; Kim, D; Lee, GH1
Hirata, T; Miyata, N; Roman, RJ; Smith, SV; Takahashi, T1
Cha, DR; Cha, JJ; Han, JY; Han, SY; Kang, YS; Song, HK1
Cui, ZH; Jiang, YJ; Jin, H; Jin, HF; Jin, JZ; Jin, YS; Li, C; Li, JJ; Piao, SG; Yang, CW; Zheng, HL1
Chen, L; Jiang, H; Liu, H; Ren, Y; Shi, K; Wang, M; Wang, Z; Wei, M1
Chen, Y; Feng, B; Gong, Y; Mu, J; Qin, Z; Shi, Z; Yuan, F; Zhang, J; Zhao, Y; Zhou, B1
He, T; Ji, Y; Lv, W; Wang, J; Zhang, Q1
Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS1
Jiang, T; Levi, M; Wang, XX1
Liu, JP; Ren, XJ; Wang, H; Wang, JY; Yu, WM1
Kohan, DE; Pollock, DM1
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F1

Reviews

2 review(s) available for isoxazoles and Diabetic Nephropathies

ArticleYear
Nuclear hormone receptors in diabetic nephropathy.
    Nature reviews. Nephrology, 2010, Volume: 6, Issue:6

    Topics: Animals; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Heat-Shock Proteins; Hepatocyte Nuclear Factor 4; Humans; Hypolipidemic Agents; Isoxazoles; Liver X Receptors; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Thiazolidinediones; Transcription Factors; Vitamin D

2010
Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.
    British journal of clinical pharmacology, 2013, Volume: 76, Issue:4

    Topics: Animals; Clinical Trials as Topic; Diabetic Nephropathies; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Isoxazoles; Kidney Failure, Chronic; Pyridines; Pyrimidines; Renal Dialysis; Renal Insufficiency, Chronic; Thiophenes; Treatment Outcome

2013

Other Studies

10 other study(ies) available for isoxazoles and Diabetic Nephropathies

ArticleYear
Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
    International journal of molecular sciences, 2022, Sep-10, Volume: 23, Issue:18

    Topics: Actins; Animals; Cadherins; Diabetic Nephropathies; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Factor V; Fibronectins; Fibrosis; Glycerophospholipids; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Kidney Tubules; Kruppel-Like Transcription Factors; Lysophospholipids; Mice; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Transcription Factors; Vimentin

2022
Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
    The Journal of pharmacology and experimental therapeutics, 2021, Volume: 376, Issue:2

    Topics: Animals; Diabetic Nephropathies; Fibrosis; Hypertension, Renal; Isoxazoles; Kidney; Lysophospholipids; Male; Propionates; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley

2021
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
    Acta diabetologica, 2021, Volume: 58, Issue:4

    Topics: Adipose Tissue; Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Insulin Resistance; Isoxazoles; Kidney; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear

2021
Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy.
    Nephron. Experimental nephrology, 2014, Volume: 126, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Isoxazoles; Leflunomide; Male; Rats; Rats, Wistar; Treatment Outcome

2014
Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
    Inflammation, 2014, Volume: 37, Issue:6

    Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred C57BL

2014
Activation of farnesoid X receptor downregulates visfatin and attenuates diabetic nephropathy.
    Molecular and cellular endocrinology, 2016, Jan-05, Volume: 419

    Topics: Animals; Cell Line; Cell Proliferation; Cytokines; Diabetic Nephropathies; Disease Models, Animal; Gene Expression Regulation; Humans; Isoxazoles; Male; Mesangial Cells; Mice; Nicotinamide Phosphoribosyltransferase; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Transcription, Genetic

2016
Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.
    Renal failure, 2016, Volume: 38, Issue:1

    Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Organ Size; Osteopontin; Rats, Wistar; Transforming Growth Factor beta1

2016
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Kidney international, 2017, Volume: 91, Issue:6

    Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta

2017
Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Chemokine CCL2; Creatinine; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Isoxazoles; Kidney; Leflunomide; Male; Nephrectomy; NF-kappa B; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha

2012
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone

2000